Complementary array formats support broad biomarker exploration and focused studies of signaling and cellular regulation.

Shirley, New York, United States, October 21, 2026 /MarketersMEDIA/ -- Creative Biolabs is highlighting three antibody array products that offer complementary approaches to protein research: a broad human biomarker proteomics array, an AKT pathway phosphorylation array, and a human autophagy array. The products provide options for researchers investigating protein abundance, signaling changes, and autophagy-related responses within a defined experimental setting.

Protein research often requires both a broad view of biological changes and a closer examination of specific molecular processes. A large screening panel can help identify candidate proteins for further study, while focused arrays can support investigation of selected pathways. Creative Biolabs' portfolio addresses these different research needs through glass slide and membrane formats.

Broad Profiling for Biomarker Exploration

The company's Human Biomarker Proteomics Antibody Array features 1,000 targets on a glass slide platform. Listed for quantitative detection of human proteins, the array accommodates sample types including cell culture supernatants, cell lysates, plasma, serum, tissue lysates, and other body fluids.

This broad coverage gives researchers an option for exploring protein profiles before selecting candidates for more focused analysis. Experimental design, sample preparation, and subsequent confirmation remain important when interpreting differences between study groups or treatment conditions.

Focused Analysis of AKT Pathway Phosphorylation

For researchers examining signaling responses, the AKT Pathway Phosphorylation Antibody Array provides a membrane-based panel of 18 targets. The product is listed for human and mouse reactivity and uses a semi-quantitative assay format.

Its panel includes phosphorylated forms of Akt, AMPKα, mTOR, PRAS40, and PTEN, among other signaling proteins. Measuring selected phosphorylation events can add information beyond protein abundance alone, helping researchers investigate how experimental conditions affect components of the AKT-related signaling network.

The array uses chemiluminescent imaging following sample incubation and antibody-based detection, offering a focused format for comparing selected signaling readouts across experimental conditions.

Connecting Signaling Studies with Autophagy Research

The Human Autophagy Antibody Array complements this pathway-focused approach with a membrane-based, semi-quantitative panel covering 20 autophagy-related targets in human samples.

AKT-related signaling and autophagy intersect through regulatory networks involving cellular growth, nutrient sensing, and stress responses. Examining these areas within the same research program may help investigators develop hypotheses about relationships between signaling changes and autophagy-related protein profiles. Measurements of protein levels, however, require complementary functional experiments to establish changes in autophagic flux.

The three products can therefore be considered at different stages of a research project, from broad protein exploration to targeted pathway analysis. They are separate research tools, and their use should be guided by the biological question, species compatibility, sample characteristics, and the information each assay measures.

Researchers can review individual product specifications and contact Creative Biolabs to discuss suitability for their experimental requirements. All three arrays are intended for research use only and are not intended for clinical use.

About Creative Biolabs

Creative Biolabs provides antibody products and research services supporting life science investigations. Its portfolio includes primary and secondary antibodies, antibody pairs, and antibody arrays for applications in protein detection, biomarker research, and cellular signaling studies.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.antibody-creativebiolabs.com/

Release ID: 89206812

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.